Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
April 16, 2021 at 05:52 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 471.510 million compared to CNY 515.143 million a year ago. Operating loss was CNY 7.682 million compared to operating Income of CNY 31.399 million a year ago. Net loss was CNY 50.983 million compared to net income of CNY 6.309 million a year ago. Basic loss per share from continuing operations was CNY 0.122 compared to basic earnings per share from continuing operations of CNY 0.015 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. 
